Research Article: Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Bacteria Infections: A Real-World Experience in the ICU
Introduction:
There has been a recent rise in the detection of carbapenem resistant gram-negative bacteria (CR-GNB), especially during infections caused by Acinetobacter baumannii, Enterobacter spp., dominated by Klebsiella pneumoniae, and Pseudomonas aeruginosa. , CR-GNB infections have limited treatment options and antimicrobial drugs, such as polymyxins and aminoglycosides, are the last line of treatment. Such drugs may cause adverse reactions, such as nephrotoxicity, and CR-GNB resistance shows an ascending trend.…
Read more